Showing posts with label Fagron. Show all posts
Showing posts with label Fagron. Show all posts

Wednesday, 16 December 2015

RARE ALERT: Fagron said to have drawn interest from Cinven et al - part 2

I have taken a lot of stick since I published my original article on Fagron, the Belgian pharmaceutical company, a few weeks ago.

Despite the somewhat sceptical tone of my original piece, some readers/followers/friends have been ribbing me for writing about Cinven's interest in purchasing Fagron, especially as the company recently called off takeover talks with potential buyers, which sent the share price plummeting.

Monday, 16 November 2015

RARE ALERT: Fagron said to have drawn interest from Cinven et al

I've been in two minds about writing on the Fagron auction. That's because there have been a lot of unsubstantiated (and possibly false) rumours going around the European markets in the last couple of weeks and as a result the stock has been volatile.

For readers unfamiliar with Fagron, it's a listed Belgian company that provides ingredients for pharmacies and hospitals. The business said last month that it had hired JP Morgan to carry out a strategic review after receiving several takeover approaches.

Back on Tip TV talking about IHS, BG Group and Fagron

It's a Monday, so here is a link to today's session on Tip TV:

http://www.tiptv.co.uk/finance/ma-roundup-renewed-worries-on-shell-bg-merger-and-the-astrazeneca-zs-farmer-deal/